Open Access

Analysis of the clinical value of 18F-FDG PET/CT in hepatic alveolar echinococcosis before and after autologous liver transplantation

  • Authors:
    • Yongde Qin
    • Xiaohong Li
    • Qizhou Zhang
    • Bin Xie
    • Xuewen Ji
    • Yubin Li
    • Amina Yiblayan
    • Hao Wen
  • View Affiliations

  • Published online on: November 12, 2015     https://doi.org/10.3892/etm.2015.2857
  • Pages: 43-48
  • Copyright: © Qin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to evaluate the clinical value of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in advanced liver alveolar echinococcosis (LAE) prior to and following autologous liver transplantation (ALT). The biodistribution of lesions in 8 patients was recorded using 18F-FDG PET/CT prior to and following surgery. The maximum standardized uptake value (SUVmax) of the lesions was also measured and compared with the pathological results. The overall hepatic peri‑lesion SUVmax of the patients was 3.57±1.21, and the delayed SUVmax was 4.19±1.70. The diagnostic sensitivity of 18F‑FDG PET/CT in LAE was 91.67%, with a specificity of 60.00% and accuracy of 82.35%. The positive predictive value was 84.62%, and the negative predictive value was 75.00%. SUVmax values of the surviving liver were 1.23±0.78 after 1 month, 1.15±0.67 after 3 months and 0.85±0.35 after 6 months. Compared with normal liver values (0.95±0.19), the 1‑month SUVmax was significantly different. The SUVmax in 3 patients with high‑lividity lesions was 2.05±0.72, and the delayed SUVmax was 3.15±0.83; 3 months after transplantation, the SUVmax was 1.85±0.62, and the delayed SUVmax was 2.95±0.79, revealing no significant difference. In conclusion, 18F‑FDG PET/CT is effective for determining the biological boundary of LAE and shows important clinical value in determining the metabolic activities of the surviving liver following ALT.
View Figures
View References

Related Articles

Journal Cover

January-2016
Volume 11 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qin Y, Li X, Zhang Q, Xie B, Ji X, Li Y, Yiblayan A and Wen H: Analysis of the clinical value of 18F-FDG PET/CT in hepatic alveolar echinococcosis before and after autologous liver transplantation. Exp Ther Med 11: 43-48, 2016
APA
Qin, Y., Li, X., Zhang, Q., Xie, B., Ji, X., Li, Y. ... Wen, H. (2016). Analysis of the clinical value of 18F-FDG PET/CT in hepatic alveolar echinococcosis before and after autologous liver transplantation. Experimental and Therapeutic Medicine, 11, 43-48. https://doi.org/10.3892/etm.2015.2857
MLA
Qin, Y., Li, X., Zhang, Q., Xie, B., Ji, X., Li, Y., Yiblayan, A., Wen, H."Analysis of the clinical value of 18F-FDG PET/CT in hepatic alveolar echinococcosis before and after autologous liver transplantation". Experimental and Therapeutic Medicine 11.1 (2016): 43-48.
Chicago
Qin, Y., Li, X., Zhang, Q., Xie, B., Ji, X., Li, Y., Yiblayan, A., Wen, H."Analysis of the clinical value of 18F-FDG PET/CT in hepatic alveolar echinococcosis before and after autologous liver transplantation". Experimental and Therapeutic Medicine 11, no. 1 (2016): 43-48. https://doi.org/10.3892/etm.2015.2857